Target Price | $18.36 |
Price | $7.47 |
Potential |
145.78%
register free of charge
|
Number of Estimates | 10 |
10 Analysts have issued a price target Novavax, Inc. 2026 .
The average Novavax, Inc. target price is $18.36.
This is
145.78%
register free of charge
$26.25
251.41%
register free of charge
$6.06
18.88%
register free of charge
|
|
A rating was issued by 14 analysts: 9 Analysts recommend Novavax, Inc. to buy, 3 to hold and 2 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Novavax, Inc. stock has an average upside potential 2026 of
145.78%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion $ | 0.68 | 1.06 |
30.65% | 55.39% | |
EBITDA Margin | -26.89% | 46.11% |
48.23% | 271.47% | |
Net Margin | -27.49% | 37.13% |
50.39% | 235.09% |
10 Analysts have issued a sales forecast Novavax, Inc. 2025 . The average Novavax, Inc. sales estimate is
This results in the following potential growth metrics:
4 Analysts have issued an Novavax, Inc. EBITDA forecast 2025. The average Novavax, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
10 Novavax, Inc. Analysts have issued a net profit forecast 2025. The average Novavax, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | -1.23 | 2.43 |
77.26% | 297.56% | |
P/E | 3.07 | |
EV/Sales | 0.67 |
10 Analysts have issued a Novavax, Inc. forecast for earnings per share. The average Novavax, Inc. EPS is
This results in the following potential growth metrics and future valuations:
Analyst | Rating | Action | Date |
---|---|---|---|
B of A Securities |
Locked
➜
Locked
|
Locked | Jul 22 2025 |
Citigroup |
Locked
➜
Locked
|
Locked | Jun 17 2025 |
JP Morgan |
Locked
➜
Locked
|
Locked | May 09 2025 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Dec 10 2024 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Nov 13 2024 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Nov 12 2024 |
Jefferies |
Locked
➜
Locked
|
Locked | Oct 16 2024 |
Analyst Rating | Date |
---|---|
Locked
B of A Securities:
Locked
➜
Locked
|
Jul 22 2025 |
Locked
Citigroup:
Locked
➜
Locked
|
Jun 17 2025 |
Locked
JP Morgan:
Locked
➜
Locked
|
May 09 2025 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Dec 10 2024 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Nov 13 2024 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Nov 12 2024 |
Locked
Jefferies:
Locked
➜
Locked
|
Oct 16 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.